Instone Real Estate Group Aktie
| 7,71EUR | 0,00EUR | 0,00% |
WKN DE: A2NBX8 / ISIN: DE000A2NBX80
Instone Real Estate Group Buy
MÜNCHEN (dpa-AFX Analyser) - Die Baader Bank hat die Einstufung für Instone nach Quartalszahlen des Immobilienentwicklers auf "Buy" mit einem Kursziel von 11 Euro belassen. Analyst Andre Remke verwies in einer am Donnerstag vorliegenden Studie auf die weiterhin hohe Bruttomarge in den abgelaufenen neun Monaten des Jahres. Das Geschäft mit Privatinvestoren gewinne an Zugkraft./ck/gl
Veröffentlichung der Original-Studie: 07.11.2024 / 09:21 / CET Erstmalige Weitergabe der Original-Studie: Datum in Studie nicht angegeben / Uhrzeit in Studie nicht angegeben / CET
Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 für das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
| Zusammenfassung: Instone Real Estate Group AG Buy | ||
|---|---|---|
|
Unternehmen: Instone Real Estate Group AG |
Analyst: Baader Bank |
Kursziel: 11,00 € |
|
Rating jetzt: Buy |
Kurs*: 8,44 € |
Abst. Kursziel*: 30,33% |
|
Rating update: Buy |
Kurs aktuell: 7,71 € |
Abst. Kursziel aktuell: 42,67% |
|
Analyst Name:: Andre Remke |
KGV*: - |
|
Nachrichten zu Instone Real Estate Group AGmehr Nachrichten
|
06.11.25 |
EQS-News: Instone Group: Very solid business performance in the first three quarters of 2025 with strong momentum in retail sales; annual targets for 2025 confirmed (EQS Group) | |
|
16.10.25 |
EQS-News: Instone Group: Major investments in new land plots strengthen the basis for future growth (EQS Group) | |
|
16.10.25 |
EQS-News: Instone Group: Erhebliche Investitionen in neue Grundstücke stärken die Basis für zukünftiges Wachstum (EQS Group) | |
|
26.09.25 |
EQS-DD: Instone Real Estate Group SE: David Dreyfus, buy (EQS Group) | |
|
26.09.25 |
EQS-DD: Instone Real Estate Group SE: David Dreyfus, Kauf (EQS Group) | |
|
24.09.25 |
EQS-DD: Instone Real Estate Group SE: David Dreyfus, buy (EQS Group) | |
|
24.09.25 |
EQS-DD: Instone Real Estate Group SE: David Dreyfus, Kauf (EQS Group) | |
|
22.09.25 |
EQS-DD: Instone Real Estate Group SE: David Dreyfus, Kauf (EQS Group) |
Analysen zu Instone Real Estate Group AGmehr Analysen
| 08.11.24 | Instone Real Estate Group Buy | Deutsche Bank AG | |
| 07.11.24 | Instone Real Estate Group Buy | Baader Bank | |
| 28.10.24 | Instone Real Estate Group Buy | Baader Bank | |
| 09.05.24 | Instone Real Estate Group Buy | Deutsche Bank AG |
Aktien in diesem Artikel
| Instone Real Estate Group AG | 7,71 | 0,00% |
|
Aktuelle Aktienanalysen
| 08:19 | NVIDIA Buy | UBS AG | |
| 08:12 | International Consolidated Airlines Outperform | Bernstein Research | |
| 08:04 | Commerzbank Buy | Deutsche Bank AG | |
| 07:45 | HUGO BOSS Outperform | RBC Capital Markets | |
| 07:45 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 07:30 | Daimler Truck Outperform | RBC Capital Markets | |
| 07:22 | Inditex Sector Perform | RBC Capital Markets | |
| 07:20 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 07:16 | Zalando Outperform | RBC Capital Markets | |
| 07:04 | SUSS MicroTec Buy | UBS AG | |
| 07:04 | GEA Sector Perform | RBC Capital Markets | |
| 06:54 | Nutrien Outperform | RBC Capital Markets | |
| 06:54 | Henkel vz. Market-Perform | Bernstein Research | |
| 06:35 | International Consolidated Airlines Overweight | JP Morgan Chase & Co. | |
| 06:34 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 06:32 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06:31 | Apple Overweight | JP Morgan Chase & Co. | |
| 06:29 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06:26 | Aumovio Overweight | JP Morgan Chase & Co. | |
| 06:25 | SUSS MicroTec Buy | Jefferies & Company Inc. | |
| 09.11.25 | Siemens Buy | Jefferies & Company Inc. | |
| 09.11.25 | Siemens Energy Buy | Jefferies & Company Inc. | |
| 07.11.25 | Siemens Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | GEA Underweight | JP Morgan Chase & Co. | |
| 07.11.25 | KRONES Buy | Jefferies & Company Inc. | |
| 07.11.25 | KRONES Kaufen | DZ BANK | |
| 07.11.25 | AB InBev Kaufen | DZ BANK | |
| 07.11.25 | Airbus Outperform | RBC Capital Markets | |
| 07.11.25 | GEA Halten | DZ BANK | |
| 07.11.25 | HENSOLDT Kaufen | DZ BANK | |
| 07.11.25 | BNP Paribas Buy | Jefferies & Company Inc. | |
| 07.11.25 | HelloFresh Halten | DZ BANK | |
| 07.11.25 | Under Armour Underweight | JP Morgan Chase & Co. | |
| 07.11.25 | Diageo Overweight | Barclays Capital | |
| 07.11.25 | Heidelberg Materials Equal Weight | Barclays Capital | |
| 07.11.25 | RATIONAL Overweight | Barclays Capital | |
| 07.11.25 | Henkel vz. Overweight | Barclays Capital | |
| 07.11.25 | UBS Underweight | Barclays Capital | |
| 07.11.25 | Zalando Equal Weight | Barclays Capital | |
| 07.11.25 | Nutrien Hold | Jefferies & Company Inc. | |
| 07.11.25 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | Fresenius Medical Care Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | Vonovia Kaufen | DZ BANK | |
| 07.11.25 | Siemens Energy Neutral | JP Morgan Chase & Co. | |
| 07.11.25 | International Consolidated Airlines Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Heidelberg Materials Outperform | RBC Capital Markets | |
| 07.11.25 | Nutrien Neutral | UBS AG | |
| 07.11.25 | AUTO1 Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | BioNTech Neutral | UBS AG |